Search

Your search keyword '"Davis, Carl W."' showing total 130 results

Search Constraints

Start Over You searched for: Author "Davis, Carl W." Remove constraint Author: "Davis, Carl W."
130 results on '"Davis, Carl W."'

Search Results

1. Severe disease during both primary and secondary dengue virus infections in pediatric populations

3. Molecular basis of SARS-CoV-2 Omicron variant evasion from shared neutralizing antibody response

4. Adjuvanted H5N1 influenza vaccine enhances both cross-reactive memory B cell and strain-specific naive B cell responses in humans

5. Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells

6. Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients

7. Light chain of a public SARS-CoV-2 class-3 antibody modulates neutralization against Omicron

8. Molecular basis of SARS-CoV-2 Omicron variant evasion from shared neutralizing antibody response

9. Structural insights for neutralization of Omicron variants BA.1, BA.2, BA.4, and BA.5 by a broadly neutralizing SARS-CoV-2 antibody

10. Human Ebola virus infection results in substantial immune activation

11. Humoral Responses Against SARS-CoV-2 and Variants of Concern After mRNA Vaccines in Patients With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

15. Structural insights for neutralization of BA.1 and BA.2 Omicron variants by a broadly neutralizing SARS-CoV-2 antibody

16. Persistence of Virus-Specific Antibody after Depletion of Memory B Cells

18. Asymmetric and non-stoichiometric glycoprotein recognition by two distinct antibodies results in broad protection against ebolaviruses

19. Immunophenotyping and Transcriptional Profiling of Human Plasmablasts in Dengue

21. Characterization of neutralizing versus binding antibodies and memory B cells in COVID-19 recovered individuals from India

22. Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells

23. Asymmetric and Non-Stoichiometric Recognition Results in Broad Protection Against Ebolaviruses by a Two-Antibody Cocktail

24. Influenza vaccine–induced human bone marrow plasma cells decline within a year after vaccination

25. Characterization of neutralizing versus binding antibodies and memory B cells in COVID-19 recovered individuals from India

27. Longitudinal Analysis of the Human B Cell Response to Ebola Virus Infection

28. In Vivo Delivery of Synthetic Human DNA-Encoded Monoclonal Antibodies Protect against Ebolavirus Infection in a Mouse Model

29. Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection

30. Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in Humans

33. Defining antigen-specific plasmablast and memory B cell subsets in human blood after viral infection or vaccination

35. Interleukin-21 Is a Critical Cytokine for the Generation of Virus-Specific Long-Lived Plasma Cells

42. Temporal expression of microRNA cluster miR-17-92 regulates effector and memory CD8+ T-cell differentiation.

44. In VivoDelivery of Synthetic Human DNA-Encoded Monoclonal Antibodies Protect against Ebolavirus Infection in a Mouse Model

45. Practical Results From Humidity Control in a Modern Printing Plant

46. Adenovirus Serotype 5 Vaccination Results in Suboptimal CD4 T Helper 1 Responses in Mice.

47. mTOR Promotes Antiviral Humoral Immunity by Differentially Regulating CD4 Helper T Cell and B Cell Responses.

48. Interleukin-21 Is a Critical Cytokine for the Generation of Virus-Specific Long-Lived Plasma Cells.

49. Molecular basis of SARS-CoV-2 Omicron variant evasion from shared neutralizing antibody response.

50. Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.

Catalog

Books, media, physical & digital resources